Mode
Text Size
Log in / Sign up

Topical clobetasol resolves recalcitrant Pagetoid reticulosis in a single case reportRare skin condition cleared with common steroid cream

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider early biopsy and immunophenotyping for refractory acral plaques to rule out Pagetoid reticulosis.

This is a case report with a literature review describing a 53-year-old woman with a 5-year history of a recalcitrant, pruritic erythematous plaque on the right ankle, initially misdiagnosed as eczema. Biopsy and immunophenotypic analysis confirmed Pagetoid reticulosis (Woringer–Kolopp disease), a rare cutaneous T-cell lymphoma. The patient was treated with topical clobetasol propionate twice daily, resulting in substantial clinical resolution.

Immunophenotyping revealed a T-cell lineage (CD3+/CD5+), loss of CD4 and CD7, predominantly absent CD2/CD8, a Ki-67 index of approximately 40%, focal CD30 positivity, and negative EBER. These findings highlight the importance of immunophenotypic evaluation in distinguishing Pagetoid reticulosis from benign inflammatory conditions.

The authors note that this is a single case report, so results cannot be generalized. They emphasize that a high index of clinical suspicion and early biopsy with immunophenotypic evaluation are essential for treatment-refractory acral plaques to avoid diagnostic delay. No adverse events or follow-up duration were reported.

How this fits prior evidence

This case report extends prior coverage of clobetasol's efficacy beyond ophthalmic use to a dermatologic indication. While a previous report described clobetasol ophthalmic nanoemulsion reducing anterior chamber cells and pain after cataract surgery, this case suggests topical clobetasol may also be effective for Pagetoid reticulosis. However, the evidence is limited to a single patient and cannot be directly compared.

A 53-year-old woman had a red, itchy patch on her ankle for five years. Doctors treated it as eczema, but it never got better. Finally, a biopsy revealed the truth: she had a rare form of skin lymphoma called Pagetoid reticulosis, also known as Woringer-Kolopp disease.

Doctors prescribed a strong topical steroid called clobetasol propionate, applied twice a day. The result was surprising: the lesion cleared up almost completely. Lab tests showed the cancer cells were a type of T-cell lymphoma, with some unusual markers. The cancer cells were growing fast, with a Ki-67 index of about 40%, meaning 40% of cells were actively dividing.

This is just one person's story, so we can't assume the same treatment will work for everyone. But it shows that when a rash doesn't respond to standard treatments, a biopsy is crucial. Early diagnosis of this rare condition can prevent years of ineffective treatment and unnecessary worry.

What this means for you:
A stubborn rash that looks like eczema may be a rare skin lymphoma; biopsy is key.

Common questions

What is Pagetoid reticulosis?

Pagetoid reticulosis, also called Woringer-Kolopp disease, is a rare type of skin lymphoma. It often looks like a red, scaly patch that doesn't heal. It's a slow-growing cancer of immune cells called T-cells.

How was it treated in this case?

In this case, the woman applied a strong steroid cream called clobetasol propionate to the affected area twice a day. After treatment, the skin lesion showed substantial clinical resolution, meaning it cleared up significantly.

Is this treatment safe for everyone?

This was a single case report, so we don't know if the treatment is safe or effective for others. Side effects were not reported in this study. Always talk to your doctor before using any medication.

How is this different from eczema?

Eczema is a common inflammatory skin condition that usually responds to steroid creams. Pagetoid reticulosis is a rare cancer that can look like eczema but doesn't get better with standard treatments. A biopsy can tell them apart.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedJun 2026
View Original Abstract ↓
Pagetoid reticulosis (PR), also known as Woringer–Kolopp disease (WKD), is a rare subtype of cutaneous T-cell lymphoma. Due to its low incidence and non-specific clinical presentation, it is frequently prone to misdiagnosis. We report the case of a 53-year-old female with a 5-year history of a recalcitrant, pruritic erythematous plaque on the right ankle, initially mismanaged as chronic eczema. Clinical examination revealed a solitary, well-demarcated, infiltrated scaly plaque at an acral site. Histopathological analysis demonstrated striking epidermotropism of medium-sized atypical lymphocytes with a pagetoid distribution and Pautrier-like microabscesses. Immunohistochemistry (IHC) revealed a T-cell lineage (CD3+/CD5+) with significant loss of CD4, CD7, and predominantly absent CD2/CD8 expression. A Ki-67 proliferation index of approximately 40% and focal CD30 positivity were observed, while EBER in situ hybridization was negative. Following a definitive diagnosis of localized PR, the patient was treated with topical clobetasol propionate twice daily, resulting in substantial clinical resolution. Literature review highlights the marked immunophenotypic heterogeneity of WKD and its favorable prognosis in localized forms. For treatment-refractory acral plaques, a high index of clinical suspicion is paramount. Early biopsy with appropriate immunophenotypic evaluation is essential to avoid diagnostic delay and guide effective local treatment, including radiotherapy or surgical excision.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.